As of May 31, 2025, Acacia Pharma Group PLC (ACPH.BR) reports a Net Margin of -5781.90%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Acacia Pharma Group PLC's Net Margin
Over recent years, Acacia Pharma Group PLC's Net Margin has shown limited historical data. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2021-12-31 | -5781.90% |
| 2020-12-31 | -15942.86% |
This trend highlights how Acacia Pharma Group PLC manages its overall profitability and cost control over time.
Comparing Acacia Pharma Group PLC's Net Margin to Peers
To better understand Acacia Pharma Group PLC's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Acacia Pharma Group PLC (ACPH.BR) | -5781.90% |
| Nutex Befektetesi Nyrt (NUTEX.BD) | 38027.55% |
| Oncoarendi Therapeutics SA (OAT.WA) | 52.28% |
| Lavipharm SA (LAVI.AT) | 16.96% |
| Vistin Pharma ASA (VISTN.OL) | 14.59% |
| Shedir Pharma Srl Unipersonale (SHE.MI) | 9.60% |
Compared to its competitors, Acacia Pharma Group PLC's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.